Saltar al contenido
Merck

Yap1-Driven Intestinal Repair Is Controlled by Group 3 Innate Lymphoid Cells.

Cell reports (2020-01-09)
Mónica Romera-Hernández, Patricia Aparicio-Domingo, Natalie Papazian, Julien J Karrich, Ferry Cornelissen, Remco M Hoogenboezem, Janneke N Samsom, Tom Cupedo
RESUMEN

Tissue repair requires temporal control of progenitor cell proliferation and differentiation to replenish damaged cells. In response to acute insult, group 3 innate lymphoid cells (ILC3s) regulate intestinal stem cell maintenance and subsequent tissue repair. ILC3-derived IL-22 is important for stem cell protection, but the mechanisms of ILC3-driven tissue regeneration remain incompletely defined. Here we report that ILC3-driven epithelial proliferation and tissue regeneration are independent of IL-22. In contrast, ILC3s amplify the magnitude of Hippo-Yap1 signaling in intestinal crypt cells, ensuring adequate initiation of tissue repair and preventing excessive pathology. Mechanistically, ILC3-driven tissue repair is Stat3 independent, but it involves activation of Src family kinases. Our findings reveal that ILC3-driven intestinal repair entails distinct transcriptional networks to control stem cell maintenance and epithelial regeneration, which implies that tissue repair and crypt proliferation can be influenced by targeting innate immune cells independent of the well-established effects of IL-22.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
3,3′-Diaminobenzidine tetrahydrochloride, tablet, 10 mg substrate per tablet
Sigma-Aldrich
Stattic, ≥98% (HPLC), powder
Sigma-Aldrich
PP2, ≥98% (HPLC)
Sigma-Aldrich
LMT-28, ≥98% (HPLC)